Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary alveolar phospholipoproteinosis].

Philippe Delaval1, Graziella Brinchault, Romain Corre

  • 1Service de Pneumologie, Centre Cardio-Pneumologique, Hôpital Pontchaillou, CHU, 35033 Rennes Cedex. philippe.delaval@chu-rennes.fr

Revue De Pneumologie Clinique
|September 6, 2005
PubMed
Summary

Pulmonary alveolar phospholipoproteinosis, a rare lung disease, can now be diagnosed without surgery using CT scans and lavage fluid analysis. New treatments targeting anti-GM-CSF antibodies offer hope for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study).

Respiratory research·2026
Same author

Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis.

Respiratory medicine and research·2026
Same author

Efficacy and safety of danazol for pulmonary fibrosis or bone-marrow failure associated with telomere-related gene mutation.

ERJ open research·2026
Same author

Behavioural changes in exposure patterns after genetic counselling among asymptomatic first-degree relatives of patients with pulmonary fibrosis and carriers of a telomere-related gene variant.

ERJ open research·2026

Area of Science:

  • Pulmonology
  • Rare Diseases
  • Immunology

Background:

  • Pulmonary alveolar phospholipoproteinosis (PAP) is a rare lung disease characterized by surfactant accumulation in alveoli.
  • The exact cause of PAP remains largely unknown.
  • Traditionally, surgical lung biopsy was the gold standard for diagnosis.

Purpose of the Study:

  • To evaluate non-invasive diagnostic methods for PAP.
  • To explore new therapeutic avenues for PAP.

Main Methods:

  • Analysis of computed tomography (CT) scan findings.
  • Examination of bronchial lavage fluid.
  • Detection of anti-GM-CSF antibodies.

Main Results:

  • Typical CT anomalies and lavage fluid patterns can confirm PAP diagnosis, obviating the need for biopsy.

Related Experiment Videos

  • The presence of anti-GM-CSF antibodies in primary PAP suggests a potential autoimmune basis.
  • Whole lung lavage remains a primary treatment modality.

    • Conclusions:

    • Non-invasive methods (CT and lavage) are sufficient for diagnosing PAP.
    • Identifying anti-GM-CSF antibodies opens new therapeutic strategies for PAP.
    • Further research into autoimmune mechanisms and targeted therapies is warranted.